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Supplementary Results
Supplementary Figure 1 | Experimental metabolomics discovery workflow. OPCs treated
with DMSO and T3 for 6 days were extracted and analyzed using untargeted HILIC/MS profiling in ESI negative mode. LC/MS data acquisition was followed by retention time correction and chromatogram alignment using online XCMS. Metabolite features whose levels significantly changed (fold change > 1.5 and p < 0.01) were filtered out and identified by MS/MS matching. The identified metabolites, as well as other key up or down-stream metabolites, which were not identified by global metabolomics analysis, were quantified by more sensitive targeted MRM analysis using authentic compound standards. A list of endogenous metabolites was prioritized for evaluation in the in vitro OPC differentiation assay. Impact on differentiation was determined based on MBP expression. In vitro OL maturation was evaluated using a co-culture assay involving primary mouse cortical neurons and OPCs. positive cells per well (n = 3 replicate cell cultures). "Bez", "Mcz" and "Tau" are the abbreviations for "benztropine", "miconazole" and "taurine"; respectively. "ns", "*", "**", "***", and "****" represent no significance, p < 0.05, p < 0.01, p < 0.001 and p < 0.0001; respectively. respectively. "ns" and "**" represent no significance, and p < 0.01; respectively. 
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